Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Experimental Neurology|July 24, 2023
Role of DNA methylation during recovery from spinal cord injury with and without β2-adrenergic receptor agonismNatalie E Scholpa
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2017
Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological TargetNatalie E Scholpa, Rick G Schnellmann
Experimental Neurology|April 15, 2020
Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseasesEpiphani C Simmons, Natalie E Scholpa, Rick G Schnellmann
Experimental Neurology|April 13, 2021
FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injuryEpiphani C Simmons, Natalie E Scholpa, Rick G Schnellmann
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2025
The β2-adrenoceptor agonist formoterol reverses metabolic dysfunction in the diabetic proximal tubuleKristan H Cleveland, Natalie E Scholpa, Rick G Schnellmann
Pharmacological Research|March 23, 2024
Serotonin regulation of mitochondria in kidney diseasesKevin Hurtado, Natalie E Scholpa, Jennifer G Schnellmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2016
Cyclin-Dependent Kinase Inhibitor 1a (p21) Modulates Response to Cocaine and Motivated BehaviorsNatalie E Scholpa, Sherri B Briggs, John J Wagner, et al.
Toxicology and Applied Pharmacology|December 14, 2020
Time-to-treatment window and cross-sex potential of β2-adrenergic receptor-induced mitochondrial biogenesis-mediated recovery after spinal cord injuryNatalie E Scholpa, Epiphani C Simmons, Josh D Crossman, et al.
Experimental Neurology|September 17, 2019
β2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injuryNatalie E Scholpa, Epiphani C Simmons, Douglas G Tilley, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2019
5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord InjuryEpiphani C Simmons, Natalie E Scholpa, Kristan H Cleveland, et al.
Pageof 4